糖尿病治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003748
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Diabetes Therapeutics Market Key Players Analysis 2031

Buy Now

美国糖尿病治疗市场受到重视Insight 合作伙伴表示,到 2021 年,这一数字将达到 584.6 亿美元,预计 2022 年至 2031 年复合年增长率为 6.8%

全球糖尿病治疗行业参与者正在经历大流行后对糖尿病药物的需求增加。糖尿病患病率的增加、久坐生活方式的增加以及高血压等其他慢性疾病发病率的增加正在推动全球糖尿病治疗市场。与此同时,人们对糖尿病自我管理意识的提高也促进了市场的增长。此外,开发负担得起且有效的糖尿病疗法(例如口服降血糖药)以及政府提供糖尿病护理设施的多项举措预计将在市场上创造利润丰厚的机会。

< span style="font-family: verdana, Geneva, sans-serif; font-size: 10pt;">北美主导着全球糖尿病治疗市场,因为该地区久坐的生活方式导致糖尿病患病率很高。由于美国肥胖率较高以及人们对糖尿病护理意识的提高,预计美国市场在预测期内将显着增长。北美仍然是最大的糖尿病治疗市场,这主要是由于美国 FDA 对各种药物和注射剂的批准增加。例如,2021年1月,诺和诺德宣布美国食品药品监督管理局(FDA)批准Fiasp(门冬胰岛素注射液)100 u/mL作为糖尿病儿童新的餐时胰岛素选择。

领先的商业参与者全球糖尿病治疗市场包括阿斯利康、勃林格殷格翰国际有限公司、礼来公司、葛兰素史克公司、默沙东公司、诺华公司、诺和诺德公司、赛诺菲公司、武田制药有限公司和辉瑞公司。市场参与者正在采用各种无机药物增加市场份额并获得竞争优势的增长战略。

一些关键进展如下:

  • 2021 年,Mankind Pharmaceuticals 与 Glenmark Pharmaceuticals 签署了一项合作营销协议,在印度销售抗糖尿病药物雷莫格列净 (remoglifozin)。这使两家公司能够扩大在亚太地区的业务。
  • 2021年,Cipla 与诺华 (Novartis) 和强生 (Johnson & Johnson) 合作营销其抗糖尿病药物 药品。此次合作扩大了公司的业务,从而巩固了其市场地位。

市场动态

1 型糖尿病人群对糖尿病治疗产品的高需求等因素正在推动市场发展。例如,根据国际糖尿病联合会的数据,糖尿病患者在 2021 年花费了 9,660 亿美元,其中其中很大一部分是 1 型糖尿病患者花费在胰岛素药物上。很少有 2 型糖尿病患者也依赖胰岛素。虽然只有 10% 的糖尿病人群是 1 型糖尿病,但他们的胰岛素摄入量较高。人们对胰岛素治疗糖尿病益处的认识不断提高,推动了对胰岛素的需求患者,尤其是新兴经济体。此外,胰岛素输送系统的快速发展、大公司的药物和类似物开发以及老年人和肥胖人口的增加正在推动全球糖尿病治疗市场的增长。

市场范围

《2031 年全球糖尿病治疗市场分析》是对糖尿病治疗市场,特别关注全球市场趋势分析。该报告旨在提供糖尿病治疗行业的概述,并按产品详细细分市场。预计全球糖尿病治疗行业在预测期内将出现高速增长. 该报告提供了主要市场参与者的市场状况的关键统计数据,并提供了 糖尿病治疗市场。

战略见解

市场细分

全球糖尿病治疗市场按产品细分。就产品而言,市场细分为 注射剂、口服抗糖尿病药物等。

该报告提供了该行业的详细概述,包括定性和定量信息。它根据各个细分市场提供了全球糖尿病治疗市场的概述和预测。它还提供了市场规模和预测估计2021年至2031年涉及五个主要地区——北美、欧洲、亚太地区(APAC)、南美洲和中美洲以及中东和非洲(MEA)。每个地区的糖尿病治疗市场随后细分为各自的市场报告涵盖了全球 18 个国家和地区的分析和预测,以及各地区当前的趋势和机遇。

从区域角度来看,北美在糖尿病治疗市场上占据主导地位,到 2021 年,其市场份额约为 41%。这种主导地位可归因于糖尿病患病率上升、久坐的生活方式以及该地区完善的医疗基础设施该地区的主要糖尿病治疗产品制造商包括阿斯利康、勃林格殷格翰国际有限公司、礼来公司、葛兰素史克公司、默沙东公司、诺华公司、诺和诺德公司、赛诺菲公司、武田制药有限公司和辉瑞公司. 这些供应商见证了医院、诊所和个人的持续需求。

Diabetes Therapeutics Market< /p>

来源:Insight Partners 分析

该报告从需求和供给两个方面分析了影响糖尿病治疗市场的因素,并进一步评估了市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还提供了详尽的波特五力模型分析强调了影响全球所有地区糖尿病治疗市场的因素。

COVID-19 大流行的影响 

COVID-19 大流行对全球糖尿病治疗市场产生了重大影响。糖尿病和不受控制的高血糖是 COVID-19 患者预后不良的危险因素,包括增加重症或死亡的风险。糖尿病患者的免疫系统较弱,COVID-19并发症会加重病情,而且免疫系统变弱的速度非常快。糖尿病患者比正常人更容易出现严重并发症。

市场参与者

这些报告涵盖了糖尿病治疗市场有机和无机增长战略的关键发展。各家公司都专注于有机增长战略,例如产品发布、产品批准、专利和事件。市场上见证的无机增长战略是收购、伙伴关系和合作。这些活动为业务扩展和市场参与者的客户群铺平了道路。糖尿病治疗市场的市场参与者是随着糖尿病治疗产品需求的不断增长,预计未来将有利润丰厚的增长机会。以下是几家从事糖尿病治疗市场的公司的名单。

该报告还包括主要糖尿病治疗市场公司的概况,以及他们的 SWOT 分析和市场策略。此外,该报告还重点关注领先行业参与者的信息,例如公司简介、提供的组件和服务、过去三年的财务信息以及过去五年的主要发展。

  • 阿斯利康
  • 勃林格殷格翰 英格海姆国际GmbH
  • 礼来公司
  • 葛兰素史克 plcMerck & Co ., Inc.Novartis AG
  • Novo Nordisk A/S
  • 赛诺菲
  • 赛诺菲
  • 武田制药有限公司
  • 辉瑞公司

Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。< /span>


Diabetes Therapeutics Market

 

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Lilly
  • Glaxosmithkline Plc
  • Merck Sharp and Dohme Corp
  • Novartis AG
  • Novo Nordisk A/S
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc
  • Glenmark
  • FDC
  • Himalaya Wellness Company
  • Janssen Global Services, LLC
  • Alembic Pharmaceuticals

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..